Intensive Care Unit versus High-dependency Care Unit for COVID-19 Patients with Invasive Mechanical Ventilation. 2023

Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
Department of Clinical Epidemiology and Health Economics, School of Public Health, and.

Rationale: High-dependency care units (HDUs), also termed "intermediate care units", "step-down units", or "respiratory HDUs", are areas in which degrees of patient care and costs are between those of the intensive care unit (ICU) and the general ward. In general, patients requiring mechanical ventilation are treated in the ICU rather than in the HDU, except for the use of HDU beds as surge capacity beds during a massive strain; however, the HDU, as well as ICU, are used as the standard care units for mechanically ventilated patients with coronavirus disease (COVID-19) in Japan. Objectives: To assess the outcomes of patients with COVID-19 with invasive mechanical ventilation treated in the HDU versus those treated in the ICU. Methods: In this retrospective cohort study, we used a multicenter inpatient database in Japan to identify mechanically ventilated patients with COVID-19 in the ICU or HDU on the start day of invasive mechanical ventilation from February 10, 2020, to November 30, 2021. The primary outcome was in-hospital mortality within 30 days from the start of the first invasive mechanical ventilation. Propensity score matching was performed to compare the outcomes of patients treated in the ICU with those treated in the HDU. Results: Of 1,985 eligible patients with COVID-19 with invasive mechanical ventilation, 1,303 (66%) were treated in the ICU, and 682 (34%) were treated in the HDU on the start day of invasive mechanical ventilation. After propensity score matching, patients treated in the ICU had significantly lower in-hospital mortality within 30 days than those treated in the HDU (18.3% vs. 24.2%; risk difference, -5.8%; 95% confidence interval, -10.9% to -0.8%). Conclusions: This multicenter observational study in Japan suggests that care for mechanically ventilated patients with COVID-19 in the ICU may significantly reduce in-hospital mortality within 30 days compared with care in the HDU. Establishing a critical care system that would allow patients with COVID-19 requiring ventilators to be treated in the ICU is desirable. Because this study was an observational study, our finding represents an association, not causation. Further studies of different critical care systems are warranted to confirm our findings.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D003422 Critical Care Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care,Intensive Care, Surgical,Surgical Intensive Care,Care, Critical,Care, Intensive,Care, Surgical Intensive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
April 1996, Critical care medicine,
Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
October 2021, Infection,
Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
May 2022, Wiener medizinische Wochenschrift (1946),
Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
May 2024, The western journal of emergency medicine,
Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
February 2022, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
February 2022, Journal of anesthesia, analgesia and critical care,
Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
February 2021, Computer methods and programs in biomedicine,
Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
August 1995, Der Internist,
Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
August 2023, Journal of neuro-oncology,
Hiroyuki Ohbe, and Yusuke Sasabuchi, and Masao Iwagami, and Takayuki Ogura, and Sachiko Ono, and Hiroki Matsui, and Hideo Yasunaga
August 2021, Diabetes care,
Copied contents to your clipboard!